Np mrd loader

Record Information
Version1.0
Created at2021-06-19 17:38:56 UTC
Updated at2021-06-29 23:50:35 UTC
NP-MRD IDNP0025556
Secondary Accession NumbersNone
Natural Product Identification
Common NameMacrolactin A
Provided ByJEOL DatabaseJEOL Logo
Description Macrolactin A is found in Bacillus sp. PP19-H3. It was first documented in 2015 (PMID: 26544726). Based on a literature review very few articles have been published on (3Z,5Z,8S,9Z,11Z,14S,16R,17Z,19Z,24R)-8,14,16-trihydroxy-24-methyl-1-oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one (PMID: 27071303) (PMID: 27792158) (PMID: 33808737) (PMID: 33184304) (PMID: 32944805) (PMID: 32673673).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC24H34O5
Average Mass402.5310 Da
Monoisotopic Mass402.24062 Da
IUPAC Name(3Z,5Z,8S,9Z,11Z,14S,16R,17Z,19Z,24R)-8,14,16-trihydroxy-24-methyl-1-oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one
Traditional Name(3Z,5Z,8S,9Z,11Z,14S,16R,17Z,19Z,24R)-8,14,16-trihydroxy-24-methyl-1-oxacyclotetracosa-3,5,9,11,17,19-hexaen-2-one
CAS Registry NumberNot Available
SMILES
[H]O[C@]1([H])\C([H])=C(\[H])/C(/[H])=C([H])\C([H])([H])[C@]([H])(O[H])C([H])([H])[C@@]([H])(O[H])\C([H])=C(\[H])/C(/[H])=C([H])\C([H])([H])C([H])([H])C([H])([H])[C@]([H])(OC(=O)\C([H])=C(\[H])/C(/[H])=C([H])\C1([H])[H])C([H])([H])[H]
InChI Identifier
InChI=1S/C24H34O5/c1-20-13-7-3-2-4-8-16-22(26)19-23(27)17-11-5-9-14-21(25)15-10-6-12-18-24(28)29-20/h2,4-6,8-12,14,16,18,20-23,25-27H,3,7,13,15,17,19H2,1H3/b4-2-,10-6-,11-5-,14-9-,16-8-,18-12-/t20-,21-,22+,23+/m1/s1
InChI KeyXXDIJWSZFWZBRM-CJPCAZISSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 500 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 100 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 200 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 300 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 400 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 600 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 700 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 800 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 900 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 1000 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, C5D5N, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Bacillus sp. PP19-H3JEOL database
    • Nagao, T., et al, J. Antibiotics 54, 333 (2001)
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP3.93ALOGPS
logP3.51ChemAxon
logS-4.4ALOGPS
pKa (Strongest Acidic)14.63ChemAxon
pKa (Strongest Basic)-1.6ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area86.99 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity123.48 m³·mol⁻¹ChemAxon
Polarizability44.97 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound101716361
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Li W, Tang XX, Yan X, Wu Z, Yi ZW, Fang MJ, Su X, Qiu YK: A new macrolactin antibiotic from deep sea-derived bacteria Bacillus subtilis B5. Nat Prod Res. 2016 Dec;30(24):2777-2782. doi: 10.1080/14786419.2016.1155576. Epub 2016 Apr 13. [PubMed:27071303 ]
  2. Yan X, Zhou YX, Tang XX, Liu XX, Yi ZW, Fang MJ, Wu Z, Jiang FQ, Qiu YK: Macrolactins from Marine-Derived Bacillus subtilis B5 Bacteria as Inhibitors of Inducible Nitric Oxide and Cytokines Expression. Mar Drugs. 2016 Oct 26;14(11). pii: md14110195. doi: 10.3390/md14110195. [PubMed:27792158 ]
  3. Fakhri S, Yarmohammadi A, Yarmohammadi M, Farzaei MH, Echeverria J: Marine Natural Products: Promising Candidates in the Modulation of Gut-Brain Axis towards Neuroprotection. Mar Drugs. 2021 Mar 19;19(3). pii: md19030165. doi: 10.3390/md19030165. [PubMed:33808737 ]
  4. Riyanti, Balansa W, Liu Y, Sharma A, Mihajlovic S, Hartwig C, Leis B, Rieuwpassa FJ, Ijong FG, Wagele H, Konig GM, Schaberle TF: Selection of sponge-associated bacteria with high potential for the production of antibacterial compounds. Sci Rep. 2020 Nov 12;10(1):19614. doi: 10.1038/s41598-020-76256-2. [PubMed:33184304 ]
  5. Salazar F, Ortiz A, Sansinenea E: A Strong Antifungal Activity of 7-O-Succinyl Macrolactin A vs Macrolactin A from Bacillus amyloliquefaciens ELI149. Curr Microbiol. 2020 Nov;77(11):3409-3413. doi: 10.1007/s00284-020-02200-2. Epub 2020 Sep 17. [PubMed:32944805 ]
  6. Sapkota M, Gao M, Li L, Yang M, Shrestha SK, Choi H, Soh Y: Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling. Eur J Pharmacol. 2020 Sep 15;883:173305. doi: 10.1016/j.ejphar.2020.173305. Epub 2020 Jul 14. [PubMed:32673673 ]
  7. Kim EN, Gao M, Choi H, Jeong GS: Marine Microorganism-Derived Macrolactins Inhibit Inflammatory Mediator Effects in LPS-Induced Macrophage and Microglial Cells by Regulating BACH1 and HO-1/Nrf2 Signals through Inhibition of TLR4 Activation. Molecules. 2020 Feb 4;25(3). pii: molecules25030656. doi: 10.3390/molecules25030656. [PubMed:32033079 ]
  8. Helaly SE, Hamad Z, El Sayed MA, Abdel-Motaal FF, Nassar MI, Ito SI, Stadler M: Bacillus methylotrophicus ASWU-C2, a strain inhabiting hot desert soil, a new source for antibacterial bacillopyrone, pyrophen, and cyclopeptides. Z Naturforsch C J Biosci. 2018 Dec 19;74(1-2):55-59. doi: 10.1515/znc-2018-0093. [PubMed:30864389 ]
  9. Chen L, Heng J, Qin S, Bian K: A comprehensive understanding of the biocontrol potential of Bacillus velezensis LM2303 against Fusarium head blight. PLoS One. 2018 Jun 1;13(6):e0198560. doi: 10.1371/journal.pone.0198560. eCollection 2018. [PubMed:29856856 ]
  10. Liu Q, Ren P, Liu Y, Qin W, Li H, Li W: Exploration of the Glycosyltransferase BmmGT1 from a Marine-Derived Bacillus Strain as a Potential Enzyme Tool for Compound Glycol-Diversification. J Microbiol Biotechnol. 2018 Jun 28;28(6):931-937. doi: 10.4014/jmb.1802.02008. [PubMed:29847868 ]
  11. Jin J, Hwang K, Joo JD, Han JH, Kim CY: Combination therapy of 7-O-succinyl macrolactin A tromethamine salt and temozolomide against experimental glioblastoma. Oncotarget. 2017 Dec 14;9(2):2140-2147. doi: 10.18632/oncotarget.23295. eCollection 2018 Jan 5. [PubMed:29416760 ]
  12. Jin J, Choi SH, Lee JE, Joo JD, Han JH, Park SY, Kim CY: Antitumor activity of 7-O-succinyl macrolactin A tromethamine salt in the mouse glioma model. Oncol Lett. 2017 May;13(5):3767-3773. doi: 10.3892/ol.2017.5918. Epub 2017 Mar 27. [PubMed:28529591 ]
  13. Souris C, Misale A, Chen Y, Luparia M, Maulide N: From Stereodefined Cyclobutenes to Dienes: Total Syntheses of Ieodomycin D and the Southern Fragment of Macrolactin A. Org Lett. 2015 Sep 18;17(18):4486-9. doi: 10.1021/acs.orglett.5b02149. Epub 2015 Sep 9. [PubMed:26349917 ]
  14. Noh K, Kang PsiW: Calculation of a First-In-Man Dose of 7-O-Succinyl Macrolactin A Based on Allometric Scaling of Data from Mice, Rats, and Dogs. Biomol Ther (Seoul). 2017 Nov 1;25(6):648-658. doi: 10.4062/biomolther.2016.192. [PubMed:28274094 ]
  15. Regmi SC, Park SY, Kim SJ, Banskota S, Shah S, Kim DH, Kim JA: The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the beta-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt. PLoS One. 2015 Nov 6;10(11):e0141753. doi: 10.1371/journal.pone.0141753. eCollection 2015. [PubMed:26544726 ]
  16. Nagao, T., et al. (2001). Nagao, T., et al, J. Antibiotics 54, 333 (2001). J. Antibiotics.